Vidas Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 54.40%
- Ebitda 54.40%
- Net Worth -2.18%
- Total Assets 24.39%
About Vidas Biotech
Vidas Biotech Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 2007 and has a history of 17 years and two months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Midas Diagnotech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Momammadmustak Saiyed and Mazarali Saiyed serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232GJ2007PTC052396
-
Company No.
052396
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Dec 2007
-
Date of AGM
22 Jan 2022
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Vidas Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Momammadmustak Saiyed
|
Additional Director | 17-May-2024 | Current |
|
Mazarali Saiyed
|
Additional Director | 17-May-2024 | Current |
Financial Performance of Vidas Biotech.
Vidas Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 54.4% increase in profit. The company's net worth dipped by a decrease of 2.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vidas Biotech?
In 2021, Vidas Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Chemie-Tech Projects LimitedMomammadmustak Saiyed and Mazarali Saiyed are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vidas Biotech?
Unlock and access historical data on people associated with Vidas Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vidas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vidas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
